| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
80,857 |
69,586 |
$3.72M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
16,873 |
14,815 |
$1.19M |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
23,244 |
19,919 |
$817K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
25,686 |
19,764 |
$716K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
9,132 |
8,162 |
$695K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
8,772 |
7,492 |
$676K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
6,775 |
6,197 |
$556K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
14,538 |
13,366 |
$479K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
9,399 |
8,619 |
$434K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
5,658 |
4,743 |
$406K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
4,296 |
3,524 |
$372K |
| 96160 |
|
31,380 |
22,566 |
$345K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
22,296 |
19,122 |
$182K |
| 92551 |
|
20,142 |
17,077 |
$160K |
| 99173 |
|
19,690 |
16,700 |
$124K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,792 |
2,516 |
$84K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
2,292 |
2,101 |
$76K |
| 99401 |
|
3,190 |
1,822 |
$75K |
| 98966 |
|
1,198 |
1,180 |
$69K |
| 96127 |
|
14,416 |
10,631 |
$66K |
| 98967 |
|
853 |
827 |
$54K |
| 96161 |
|
3,086 |
2,570 |
$47K |
| 99605 |
|
755 |
730 |
$45K |
| 36416 |
|
21,228 |
18,213 |
$42K |
| 99050 |
|
1,620 |
1,502 |
$26K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,984 |
1,826 |
$24K |
| 83655 |
|
2,147 |
1,776 |
$24K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,900 |
887 |
$23K |
| 90677 |
|
470 |
400 |
$22K |
| 3008F |
|
24,661 |
20,995 |
$21K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,133 |
909 |
$20K |
| D1206 |
Topical application of fluoride varnish |
895 |
876 |
$16K |
| 99215 |
Prolong outpt/office vis |
98 |
77 |
$11K |
| D0190 |
|
893 |
877 |
$9K |
| 80061 |
Lipid panel |
651 |
531 |
$8K |
| 87807 |
|
699 |
641 |
$7K |
| 94760 |
|
4,786 |
4,135 |
$6K |
| 81003 |
|
3,018 |
2,598 |
$6K |
| 90651 |
|
602 |
480 |
$5K |
| 99177 |
|
750 |
663 |
$5K |
| 0001A |
|
167 |
132 |
$5K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
72 |
42 |
$5K |
| 0002A |
|
140 |
116 |
$4K |
| 90461 |
|
9,399 |
7,944 |
$4K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
227 |
196 |
$4K |
| 82962 |
|
966 |
834 |
$3K |
| 90670 |
|
3,498 |
2,857 |
$3K |
| 36415 |
Collection of venous blood by venipuncture |
1,233 |
1,035 |
$3K |
| 99051 |
|
4,031 |
3,738 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
127 |
125 |
$2K |
| 90473 |
|
170 |
147 |
$1K |
| 90619 |
|
96 |
83 |
$1K |
| 99381 |
|
18 |
12 |
$1K |
| 98968 |
|
14 |
14 |
$1K |
| 90680 |
|
1,701 |
1,375 |
$667.34 |
| 90710 |
|
138 |
110 |
$600.00 |
| 90686 |
|
4,160 |
3,718 |
$597.94 |
| 90688 |
|
1,236 |
1,132 |
$510.55 |
| 90734 |
|
199 |
156 |
$501.73 |
| 90698 |
|
2,463 |
2,136 |
$500.00 |
| 90621 |
|
13 |
12 |
$468.00 |
| 0071A |
|
13 |
12 |
$429.28 |
| 81025 |
|
66 |
53 |
$338.62 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
297 |
280 |
$325.76 |
| 90633 |
|
679 |
587 |
$251.32 |
| 94664 |
|
13 |
12 |
$215.36 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
132 |
65 |
$166.57 |
| 90661 |
|
199 |
165 |
$151.73 |
| 90715 |
|
89 |
80 |
$96.31 |
| 90785 |
|
32 |
12 |
$88.23 |
| 90744 |
|
313 |
291 |
$84.00 |
| 90672 |
|
225 |
164 |
$82.76 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
218 |
196 |
$75.90 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
232 |
208 |
$26.32 |
| 99000 |
|
34,666 |
30,393 |
$12.16 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
485 |
447 |
$9.09 |
| 90674 |
|
999 |
890 |
$0.00 |
| 90697 |
|
295 |
215 |
$0.00 |
| 90716 |
|
144 |
130 |
$0.00 |
| 90696 |
|
12 |
12 |
$0.00 |
| 90687 |
|
374 |
353 |
$0.00 |
| 91300 |
|
612 |
498 |
$0.00 |
| 90707 |
|
104 |
90 |
$0.00 |
| 90685 |
|
48 |
47 |
$0.00 |